2022
DOI: 10.3390/coatings12070967
|View full text |Cite
|
Sign up to set email alerts
|

Special Issue: Multifunctional Coatings in Orthopedic Implants

Abstract: As technology continues to advance, implants are widely used in orthopedic surgery, such as the fixation of fractures, artificial joints, the reconstruction of the spine and the correction of skeletal deformities [...]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…The formation of biofilms at implants significantly impairs the efficacy of antibiotic treatment by increasing the antibiotic resistance of internal biofilm cells by 10–1000 times [ 18 ]. This necessitates efforts to design safe and efficacious strategies for targeting implant-associated infections and effectively combating the development of biofilms through implant surface modifications and the use of biomaterials with excellent anti-biofouling properties, and assist, therefore, host tissues around the implants in winning “the race for the surface” [ 19 , 20 ]. As an alternative to systemic antibiotic use, the FDA has approved various biomaterial candidates that can be used for targeting IAIs [ 21 ].…”
Section: Introductionmentioning
confidence: 99%
“…The formation of biofilms at implants significantly impairs the efficacy of antibiotic treatment by increasing the antibiotic resistance of internal biofilm cells by 10–1000 times [ 18 ]. This necessitates efforts to design safe and efficacious strategies for targeting implant-associated infections and effectively combating the development of biofilms through implant surface modifications and the use of biomaterials with excellent anti-biofouling properties, and assist, therefore, host tissues around the implants in winning “the race for the surface” [ 19 , 20 ]. As an alternative to systemic antibiotic use, the FDA has approved various biomaterial candidates that can be used for targeting IAIs [ 21 ].…”
Section: Introductionmentioning
confidence: 99%